Targeting α-synuclein as a therapeutic strategy for Parkinson’s disease
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728222.2015.1062877
Reference97 articles.
1. Prodromal non-motor symptoms of Parkinson's disease
2. Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease
3. Human α4β2 Nicotinic Acetylcholine Receptor as a Novel Target of Oligomeric α-Synuclein
4. Abrogation of -synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats
5. BAG1 is Neuroprotective in In Vivo and In Vitro Models of Parkinson’s Disease
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Beyond canonical PROTAC: biological targeted protein degradation (bioTPD);Biomaterials Research;2023-07-21
2. Development of non-viral vectors for neuronal-targeted delivery of CRISPR-Cas9 RNA-proteins as a therapeutic strategy for neurological disorders;Biomaterials Science;2022
3. α-Synuclein in Parkinson’s Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role?;The Neuroscientist;2020-07-30
4. Specific Knockdown of α-Synuclein by Peptide-Directed Proteasome Degradation Rescued Its Associated Neurotoxicity;Cell Chemical Biology;2020-06
5. Pharmacological Targeting of Microglial Activation: New Therapeutic Approach;Frontiers in Cellular Neuroscience;2019-11-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3